Introduction: Primary biliary cholangitis (PBC) is an infrequent, immune-mediated cholestatic liver disease, which can lead to liver fibrosis, cirrhosis and complications of end-stage liver disease. The established goals of treatment of PBC are prevention of end-stage liver disease and amelioration of associated symptoms. The European Association for the Study of the Liver (EASL) management guidelines provide extensive recommendations on the diagnosis and management of PBC. Areas covered: This article describes the development by expert consensus of a ‘PBC Integrated Patient Care Pathway’ to simplify and standardize the management of PBC for clinicians based on current practice. Expert opinion: Guideline adoption is potentially poor in practice since most patients with PBC in the community are seen by general gastroenterologists or hepatologists without a special interest in autoimmune liver disease. The PBC Integrated Patient Care Pathway is a best practice tool for clinicians designed to complement the EASL Clinical Practice Guidelines for the diagnosis and management of PBC patients. It gives clinicians a practical decision tree of the key steps in PBC management, thereby providing a simplified framework and an opportunity for more uniform practice that supports the safe and timely adoption of varied models of care provision to patients with PBC.

Hirschfield, G., Chazouilleres, O., Cortez-Pinto, H., Macedo, G., de Ledinghen, V., Adekunle, F., et al. (2021). A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 15(8), 929-939 [10.1080/17474124.2021.1945919].

A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients

Carbone M.
Ultimo
Membro del Collaboration Group
2021

Abstract

Introduction: Primary biliary cholangitis (PBC) is an infrequent, immune-mediated cholestatic liver disease, which can lead to liver fibrosis, cirrhosis and complications of end-stage liver disease. The established goals of treatment of PBC are prevention of end-stage liver disease and amelioration of associated symptoms. The European Association for the Study of the Liver (EASL) management guidelines provide extensive recommendations on the diagnosis and management of PBC. Areas covered: This article describes the development by expert consensus of a ‘PBC Integrated Patient Care Pathway’ to simplify and standardize the management of PBC for clinicians based on current practice. Expert opinion: Guideline adoption is potentially poor in practice since most patients with PBC in the community are seen by general gastroenterologists or hepatologists without a special interest in autoimmune liver disease. The PBC Integrated Patient Care Pathway is a best practice tool for clinicians designed to complement the EASL Clinical Practice Guidelines for the diagnosis and management of PBC patients. It gives clinicians a practical decision tree of the key steps in PBC management, thereby providing a simplified framework and an opportunity for more uniform practice that supports the safe and timely adoption of varied models of care provision to patients with PBC.
Articolo in rivista - Review Essay
American association for the study of liver diseases (aasld); european association for the study of the liver (easl); obeticholic acid (oca); patient care pathway; primary biliary cholangitis (pbc); ursodeoxycholic acid (udca);
English
7-lug-2021
2021
15
8
929
939
none
Hirschfield, G., Chazouilleres, O., Cortez-Pinto, H., Macedo, G., de Ledinghen, V., Adekunle, F., et al. (2021). A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 15(8), 929-939 [10.1080/17474124.2021.1945919].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/350904
Citazioni
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 0
Social impact